Copyright
©The Author(s) 2022.
World J Hepatol. Feb 27, 2022; 14(2): 354-371
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.354
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.354
Figure 1 Factors that can increase the risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease/metabolic-dysfunction associated fatty liver disease.
Presence of cirrhosis is the factor that has the greatest influence on the incidence of hepatocellular carcinoma. HCC: Hepatocellular carcinoma.
- Citation: Fassio E, Barreyro FJ, Pérez MS, Dávila D, Landeira G, Gualano G, Ruffillo G. Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations? World J Hepatol 2022; 14(2): 354-371
- URL: https://www.wjgnet.com/1948-5182/full/v14/i2/354.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i2.354